Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 15/20 | 0.56 |
| ▸ | CTSB | P07858 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7844670 | 0.87 | CTSD (0.61) | CTSDCTSB | |
| SCHEMBL9296046 | 0.84 | CTSD (0.63) | CTSDCTSB | |
| SCHEMBL9296051 | 0.84 | CTSD (0.63) | CTSDCTSB | |
| SCHEMBL32889357 | 0.83 | ACE (0.62) | CTSD | |
| SCHEMBL29822546 | 0.82 | CTSD (0.55) | CTSDCTSB | |
| SCHEMBL11061687 | 0.81 | CTSD (0.57) | CTSDCTSB | |
| SCHEMBL11061679 | 0.81 | CTSD (0.57) | CTSDCTSB | |
| SCHEMBL29876711 | 0.80 | ACE (0.58) | CTSD | |
| SCHEMBL30051899 | 0.80 | ACE (0.65) | CTSD | |
| SCHEMBL29608926 | 0.80 | MME (0.46) | CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230310521-A1 | COMBINATION COMPRISING BACILLUS AND AN ESSENTIAL OIL AND METHODS FOR MAKING AND USING | PHIBRO ANIMAL HEALTH CORPORATION (US) | 2023-10-05 | — | — | US | disclosed |
| US-11723919-B2 | Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D | PHIBRO ANIMAL HEALTH CORPORATION (US) | 2023-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11723919-B2 | Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D | VDR, CYP24A1, GC | CTSD 145/4885CTSB 3972/4885 |
| US-20230310521-A1 | COMBINATION COMPRISING BACILLUS AND AN ESSENTIAL OIL AND METHODS FOR MAKING AND USING | CHIA, YBX3, XPA | CTSD 2562/4885CTSB 2377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.